130 related articles for article (PubMed ID: 32163858)
1. Circulating CTLA-4 levels and CTLA4 polymorphisms associate with disease condition and progression and hepatocellular carcinoma patients' survival in chronic hepatitis B virus infection.
Wang L; Li N; Fan X; Wang X; Zhang X; Zhang K; Han Q; Lv Y; Liu Z
Int Immunopharmacol; 2020 Mar; 82():106377. PubMed ID: 32163858
[TBL] [Abstract][Full Text] [Related]
2. Autophagy-Related 5 Gene rs510432 Polymorphism Is Associated with Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection.
Li N; Fan X; Wang X; Deng H; Zhang K; Zhang X; Han Q; Lv Y; Liu Z
Immunol Invest; 2019 May; 48(4):378-391. PubMed ID: 30907204
[TBL] [Abstract][Full Text] [Related]
3. [Association of CTLA4 gene +49G/A polymorphism with HBV infection and HBV-related hepatocellular carcinoma in Hunan Han population].
Liu G; Lu GX
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1838-40. PubMed ID: 20813679
[TBL] [Abstract][Full Text] [Related]
4. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
6. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
7. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
[TBL] [Abstract][Full Text] [Related]
8. Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection.
Li F; Li N; Sang J; Fan X; Deng H; Zhang X; Han Q; Lv Y; Liu Z
Cancer Manag Res; 2018; 10():941-951. PubMed ID: 29760564
[TBL] [Abstract][Full Text] [Related]
9. Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population.
Peng Q; Li H; Lao X; Deng Y; Chen Z; Qin X; Li S
Infect Genet Evol; 2014 Oct; 27():375-81. PubMed ID: 25173083
[TBL] [Abstract][Full Text] [Related]
10. Association between CTLA-4 rs231775 polymorphism and hepatocellular carcinoma susceptibility.
Liu Z; Song Z; Sun J; Sun F; Li C; Sun J; Xu L
Int J Clin Exp Pathol; 2015; 8(11):15118-22. PubMed ID: 26823853
[TBL] [Abstract][Full Text] [Related]
11. Association of cytotoxic T-lymphocyte antigen-4 + 49A/G gene polymorphism with hepatocellular carcinoma risk in Chinese.
Wang C; Liu W; Zhao L; Dong Z
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1117-S1120. PubMed ID: 30539855
[TBL] [Abstract][Full Text] [Related]
12. Association of LIN28B polymorphisms with chronic hepatitis B virus infection.
Han Q; Sang J; Fan X; Wang X; Zeng L; Zhang X; Zhang K; Li N; Lv Y; Liu Z
Virol J; 2020 Jun; 17(1):81. PubMed ID: 32571380
[TBL] [Abstract][Full Text] [Related]
13. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
[TBL] [Abstract][Full Text] [Related]
14. +49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population.
Gu X; Qi P; Zhou F; Ji Q; Wang H; Dou T; Zhao Y; Gao C
Hum Immunol; 2010 Jan; 71(1):83-7. PubMed ID: 19778566
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population.
Yao JY; Chao K; Li MR; Wu YQ; Zhong BH
World J Gastroenterol; 2015 Apr; 21(14):4232-9. PubMed ID: 25892873
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
Cheong JY; Shin HD; Cho SW; Kim YJ
J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
[TBL] [Abstract][Full Text] [Related]
17. Association of LTBR polymorphisms with chronic hepatitis B virus infection and hepatitis B virus-related hepatocellular carcinoma.
Zhu Q; Li N; Li F; Sang J; Deng H; Han Q; Lv Y; Li C; Liu Z
Int Immunopharmacol; 2017 Aug; 49():126-131. PubMed ID: 28575727
[TBL] [Abstract][Full Text] [Related]
18. Association between microRNA-196A2 and microRNA-146A polymorphisms and progression to cirrhosis and hepatocellular carcinoma in patients with viral hepatitis B.
Riazalhosseini B; Mohamed Z; Apalasamy YD; Eng HS; Mohamed R
Pharmacogenet Genomics; 2016 Feb; 26(2):74-9. PubMed ID: 26529280
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus.
Hoan NX; Khuyen N; Giang DP; Binh MT; Toan NL; Anh DT; Trung NT; Bang MH; Meyer CG; Velavan TP; Song LH
BMC Med Genet; 2019 Dec; 20(1):201. PubMed ID: 31864292
[TBL] [Abstract][Full Text] [Related]
20. Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals.
Chuaypen N; Tuyapala N; Pinjaroen N; Payungporn S; Tangkijvanich P
BMC Med Genet; 2019 May; 20(1):87. PubMed ID: 31117968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
